Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
9.32
-0.08 (-0.85%)
At close: Apr 15, 2025, 4:00 PM
9.31
-0.01 (-0.15%)
Pre-market: Apr 16, 2025, 7:42 AM EDT
COEP Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for COEP.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for COEP.
Recommendation Trends
Rating | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +543.78% | Sep 22, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $200 | Strong Buy | Initiates | $200 | +2,045.92% | May 25, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +1,187.55% | May 18, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +1,187.55% | May 10, 2023 |
JonesTrading | JonesTrading | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +758.37% | Apr 19, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.17
from -5.10
EPS Next Year
-0.17
from -0.17
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.18 | -0.18 | -0.19 |
Avg | -0.17 | -0.17 | -0.18 |
Low | -0.17 | -0.17 | -0.18 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.